Copyright
©The Author(s) 2022.
World J Clin Oncol. Oct 24, 2022; 13(10): 813-821
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.813
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.813
Table 2 Odds ratio were calculated using a contingency table
Severe oral mucositis | No severe oral mucositis | Total | |
Dentoxol® | a | b | a + b |
Control | c | d | c + d |
Total | a + c | b + d | a + b + c + d |
- Citation: Solé S, Becerra S, Carvajal C, Bettolli P, Letelier H, Santini A, Vargas L, Cifuentes A, Larsen F, Jara N, Oyarzún J, Bustamante E, Martínez B, Rosenberg D, Galván T. Clinical relevance of the use of Dentoxol® for oral mucositis induced by radiotherapy: A phase II clinical trial. World J Clin Oncol 2022; 13(10): 813-821
- URL: https://www.wjgnet.com/2218-4333/full/v13/i10/813.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i10.813